369 related articles for article (PubMed ID: 36420005)
1. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.
Su W; Chen M; Xiao L; Du S; Xue L; Feng R; Ye W
Front Public Health; 2022; 10():1047794. PubMed ID: 36420005
[TBL] [Abstract][Full Text] [Related]
2. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J;
Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301
[TBL] [Abstract][Full Text] [Related]
3. MAFLD and risk of CKD.
Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
[TBL] [Abstract][Full Text] [Related]
4. Kidney disease parameters, metabolic goal achievement, and arterial stiffness risk in Chinese adult people with type 2 diabetes.
Xu C; Li L; Shi J; Ji B; Zheng Q; Wang Y; Ke T; Li L; Zhao D; Dai Y; Xu F; Peng Y; Zhang Y; Dong Q; Wang W
J Diabetes; 2022 May; 14(5):345-355. PubMed ID: 35510608
[TBL] [Abstract][Full Text] [Related]
5. Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry.
Yeh YK; Lin KH; Sheu WH; Lo SH; Yeh YP; Huang CN; Hwu CM; Lu CH
BMC Nephrol; 2024 Apr; 25(1):133. PubMed ID: 38622535
[TBL] [Abstract][Full Text] [Related]
6. Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study.
Hu Q; Chen Y; Bao T; Huang Y
Ren Fail; 2022 Dec; 44(1):1996-2005. PubMed ID: 36374233
[TBL] [Abstract][Full Text] [Related]
7. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.
Okubo A; Nakashima A; Doi S; Doi T; Ueno T; Maeda K; Tamura R; Yamane K; Masaki T
Clin Exp Nephrol; 2020 May; 24(5):435-443. PubMed ID: 32076888
[TBL] [Abstract][Full Text] [Related]
8. Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study.
Cen C; Fan Z; Ding X; Tu X; Liu Y
Sci Rep; 2024 Jun; 14(1):12645. PubMed ID: 38825630
[TBL] [Abstract][Full Text] [Related]
9. MAFLD and glomerular hyperfiltration in subjects with normoglycemia, prediabetes and type 2 diabetes: A cross-sectional population study.
Abbate M; Parvanova A; López-González ÁA; Yañez AM; Bennasar-Veny M; Ramírez-Manent JI; Reseghetti E; Ruggenenti P
Diabetes Metab Res Rev; 2024 May; 40(4):e3810. PubMed ID: 38757431
[TBL] [Abstract][Full Text] [Related]
10. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease.
Tanaka M; Mori K; Takahashi S; Higashiura Y; Ohnishi H; Hanawa N; Furuhashi M
Nephrol Dial Transplant; 2023 Feb; 38(3):700-711. PubMed ID: 35612975
[TBL] [Abstract][Full Text] [Related]
11. Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study.
Rodriguez-Poncelas A; Coll-De Tuero G; Turrò-Garriga O; Barrot-de la Puente J; Franch-Nadal J; Mundet-Tuduri X;
BMC Nephrol; 2014 Sep; 15():150. PubMed ID: 25227555
[TBL] [Abstract][Full Text] [Related]
12. The Role of Metabolic Dysfunction-Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study.
Wei S; Song J; Xie Y; Huang J; Yang J
JMIR Public Health Surveill; 2023 May; 9():e45050. PubMed ID: 37140958
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.
Friedman AN; Wang J; Wahed AS; Docherty NG; Fennern E; Pomp A; Purnell JQ; le Roux CW; Wolfe B
Am J Kidney Dis; 2019 Dec; 74(6):761-770. PubMed ID: 31331758
[TBL] [Abstract][Full Text] [Related]
14. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
[TBL] [Abstract][Full Text] [Related]
15. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
[TBL] [Abstract][Full Text] [Related]
16. Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria.
Liu Y; Chai S; Zhang X
J Diabetes; 2024 Feb; 16(2):e13501. PubMed ID: 37974383
[TBL] [Abstract][Full Text] [Related]
17. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
[TBL] [Abstract][Full Text] [Related]
18. Association of Stroke With Metabolic Dysfunction-Associated Fatty Liver Disease With and Without CKD.
Li Y; Wu S; Gao J; Zhang Y; Zuo Y; Tian X; Chen S; Xing A; Wang A; He Y
Am J Kidney Dis; 2024 Apr; 83(4):477-488. PubMed ID: 37838141
[TBL] [Abstract][Full Text] [Related]
19. The Lower Limit of Reference of Urinary Albumin/Creatinine Ratio and the Risk of Chronic Kidney Disease Progression in Patients With Type 2 Diabetes Mellitus.
Tang WH; Hung WC; Wang CP; Wu CC; Hsuan CF; Yu TH; Hsu CC; Cheng YA; Chung FM; Lee YJ; Lu YC
Front Endocrinol (Lausanne); 2022; 13():858267. PubMed ID: 35721762
[TBL] [Abstract][Full Text] [Related]
20. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S
Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
